Viewing Study NCT00924066

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:24 PM
Ignite Modification Date: 2026-05-19 @ 3:39 PM
Study NCT ID: NCT00924066
Status: TERMINATED
Last Update Posted: 2019-11-21
First Post: 2009-06-17
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Ixabepilone to Treat Cervical Cancer
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cervical Carcinoma View
None Cervical Adenocarcinoma View
None Cervical Adenosquamous Carcinoma View
None Cervical Carcinoma, Non-SquamousType View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ixabepilone View
None BMS-247550 View
None Ixempra View
None Cervical Cancer View
None Epothilone View